3Lazzeroni E,Rolli A,Aurier E,et al.Clinical significance of coronary artery disease in hypertrophic cardiomyopathy[J].Am J Cardiol,1992,70(4):499-501.
4Suzuki J,Watanabe F,Takenaka K,et al.New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of makedly inverted T waves[J].J Am Coll Cardiol,1993,22(4):1175-1181.
5O'Gran PT,Bonow RO,Maron BJ,et al.Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy:assessment with thalium 201 emission computed tomography[J].Circulation,1987,76(6):1214-1223.
6王荣福.核医学.2版.北京:北京大学医学出版社,2009:178-183.
7李少林,王荣福.核医学.7版.北京:人民卫生出版社,2008:38-48.
8Dobrucki LW,Sinusas AJ.PET and SPE CT in cardiovascular molecular imaging.Nat Rev C ardiol,2010,7(1):38-47.
9Kiat H,M addahi J,Roy LT,et al.Comparison of technetium 99 m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods.Am Heart J,1989,117(1):1-11.
10Acampa W,Cuocolo A,Sullo P,et al.Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease.J Nucl Cardiol,1998,5(3):265-274.
